EGFR and non-small cell lung carcinoma: Considering the immediate symptomatic improvement with the correct EGFR-TKI treatment, the ultra-rapid turnaround time of BALF liquid biopsy is potentially beneficial for advanced NSCLC patients who need urgent therapeutic intervention, especially symptomatic or critically ill patients.